lipoxin a4 has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Duan, X; Gan, L; He, M; Hu, F; Liu, X; Ming, Z; Poorun, D; Wang, X; Xu, J; Zhang, S; Zhu, K | 1 |
| Chen, H; Furue, M; Moroi, Y; Nakahara, T; Takahara, M; Takeuchi, S; Tu, Y; Uchi, H; Xie, L | 1 |
2 other study(ies) available for lipoxin a4 and Psoriasis
| Article | Year |
|---|---|
Lipoxin A4 and its analog suppress inflammation by modulating HMGB1 translocation and expression in psoriasis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Disease Models, Animal; Female; Gene Expression Regulation; Heptanoic Acids; HMGB1 Protein; Immunohistochemistry; Inflammation Mediators; Keratinocytes; Lipoxins; Mice; Protein Transport; Psoriasis; Signal Transduction; Toll-Like Receptor 4 | 2017 |
Lipoxin A(4), a potential anti-inflammatory drug targeting the skin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cytokines; Epidermis; Fibroblasts; Gene Expression Regulation; Humans; Inflammation; Interleukin-6; Interleukin-8; Keratinocytes; Lipoxins; Models, Biological; Psoriasis; Skin | 2011 |